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Cancer of the uterine corpus has gained importance over the past several years. Treatment modalities such as surgery, radiation and hormonal manipulations have been refined without fundamental changes. Between 1955 and 1985 381 patients were admitted for primary treatment of endometrial cancer at the department of gynecology, 5~6 of these were treated with curative intent. Treatment consisted of surgery (TANBSO) with or without rediatien or of radiation only combining intr~ cavitary and external beam techniques. Some patients were also given progestatienal agents. Overall survival was the endpoint of our evaluation. Analysis was performed uslng the SAS computer program. Survival rates were calculated with the life table method {BMOP soft-were). The overall survival of the entire group after 5 years was 65,7 %~ SE 2,5. 5 year-survival by stage: I (n:284): 73,7 % SE 2,7, IZ (n:] Comparison with ether radiolegie procedures (hysterography, percutaneous oltseoond~ GTI shews that hysteros~nography is the best suitable eethod for determenmtion of the macroscopie finn structure. Hysterosonography enables as as the first methud to determine before therapy the depth of infiltration and the extension of carcinomas within the uterus. If necessary the operative procedure may be altered. In case of a radiotherapy the exact target volume for intracavity radiotherapy can be determined, lhe optimal isodose carves can be directly uverlaid over the hysterosonographic pictures. Till now 44 cases have been treated rmdiologimally after having been controlled by this new modality. Estrogen (ER) and Progesterone (PR) receptors are engaged in the physiological cyclic changes of the normal endometrium in premenopausal female. Endometrial carcinomas also possess ER und PR, however, in a considerably lower concentration. Gestagen treatment of advanced endo~ metrial cancer with unknown receptorstatus is e~fective only in about 30 percent whereas in recepterpositive cases hormonal treatment shows better results according to recent publications. lissue samples o~ 168 patients with endometrial carcinomas in different stages were surgically removed; corresponding tissue was then taken to usual histological investigation and receptor determination by dextran coated charcoal (DDC) method. According to Young et el. (1976) and Ehrlich et el. (1981) a borderline o~ > 50 fmol/ml protein was decided to be raceptorpositive. Receptor mum tent of endometrial cancer was then correlated to anamnestica] and clinical data. In 130 patients data were col-!ected in an observation period o~ more than 6 months up to 5 years and a life table analysis could be performed (siemens SPSS). In 60 percent of all cases both receptors could be demonstrated, 15 percent had only one receptor, 25 percent we ~ re receptornegative. 7here were no differences regarding anamnestical data (menarche, menopause, parity) between receptorpositive and negative patients. Regarding clinical data correlations between receptorstatus and clinical stage, histological differentiation and myemetrial invasion could be confirmed: well differentiated carcinomas in early stage were more frequent receptorpesitive than poorly differentiated in advanced stage. Life table aria lysis of 130 patients showed a significant longer survi val time of patients with steroidreceptorpositive endometrial cancer separated into staqe with nearly identical stage adapted treatment. Univ.-Frauenklinik, Hugstetterstr,55, D 7800 Freiburg
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